Jacobs Levy Equity Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Buy
+133,110
New +$1.71M 0.01% 586
2026
Q1
Sell
-95,498
Closed -$917K 986
2025
Q4
$917K Sell
95,498
-428,790
-82% -$4.05M ﹤0.01% 696
2025
Q3
$4.97M Buy
524,288
+387,440
+283% +$3.26M 0.02% 426
2025
Q2
$1.02M Buy
136,848
+23,613
+21% +$147K ﹤0.01% 754
2025
Q1
$688K Buy
113,235
+39,698
+54% +$275K ﹤0.01% 878
2024
Q4
$572K Buy
+73,537
New +$548K ﹤0.01% 796

Other funds holding CYRX

Jacobs Levy Equity Management's CYRX Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in CryoPort (CYRX) in Q2 2026: 133,110 shares worth $2.09M. The stake represents 0.01% of the portfolio and ranks #586 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in CYRX as recently as Q4 2025.

Jacobs Levy Equity Management first reported a position in CYRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.97M in Q3 2025. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Jacobs Levy Equity Management held 133,110 shares of CryoPort worth $2.09M as of Q2 2026.
  • CryoPort was a new Jacobs Levy Equity Management position in Q2 2026.
  • CryoPort made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #586 holding.
  • Jacobs Levy Equity Management first reported a position in CryoPort in Q4 2024 and has held it in 6 quarters since.
  • Jacobs Levy Equity Management's CryoPort position peaked at $4.97M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.